EWTX - Wall Street Estimates - Edgewise Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 26.26

-1.72 %

$ 2.49 B

Market Cap

-17.51

P/E

Price Target Average

77.46%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

7.65%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Edgewise Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for EWTX of $46.6 , with forecasts ranging from a low of $42 to a high of $51 .

EWTX Lowest Price Target Wall Street Target

42 USD 59.94%

EWTX Average Price Target Wall Street Target

46.6 USD 77.46%

EWTX Highest Price Target Wall Street Target

51 USD 94.21%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free